Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Indutrade acquires Dutch producer of machine knifes

Indutrade has signed an agreement to acquire all shares in the Dutch company Tebra Messen Industrie B.V., www.tebra.nl, with annual sales of approximately EUR 5 million (SEK 52 million).Tebra is one of the largest producers of machine knives in the Netherlands, serving domestic and international clients with reliable machine knives used in a range of different sectors and industries such as food processing, rubber, recycling, packaging and hygiene. The comprehensive product range, covering stainless steel blades, special knives, rotary die cutters, circular blades and shear blades is

Vitamin D supplementation seems to alleviate depressive symptoms in adults

An extensive meta-analysis suggests that vitamin D supplementation may alleviate depressive symptoms in adults with depression. Conducted by an international team of researchers, the meta-analysis includes dozens of studies from around the world. Depressive symptoms cause a significant disease burden worldwide. The therapeutic efficacy of current antidepressants is often insufficient, which is why further ways to alleviate the symptoms of depression have been sought, for example, from nutritional research. Vitamin D is believed to regulate central nervous system functions the

MPC Container Ships ASA announces date for Q2 and six-month 2022 results

Oslo, 12 August 2022 - MPC Container Ships ASA (the "Company") will be releasing its second quarter 2022 report prior to market opening on Thursday 18 August 2022. The Company will host a webcast for the presentation of the Q2 2022 results commencing on Thursday 18 August 2022 at 15:00 hours CEST / 09:00 hours EDT. The presentation will be made available on the Company’s webpage from 12:00 hours CET / 06:00 hours EDT. There will be a Q&A session after the presentation. The event is being streamed. It is recommended that you listen

Publication of United Bankers Plc’s 2022 Half-Year Financial Report and invitation to result presentation on 26 August 2022

United Bankers Plc Press release 12 August 2022 at 09:00 EEST   Publication of United Bankers Plc’s 2022 Half-Year Financial Report and invitation to result presentation on 26 August 2022   United Bankers Plc will publish its Half-Year Financial Report for the period January-June 2022 on Friday 26 August 2022 at approximately 9.00 am. The Half-Year Financial Report will be available on the company’s website at www.unitedbankers.fi  after publishing. Patrick Anderson, CEO, will present the result to analysts and press at the

Cantargia announces final outcome of the company’s significantly oversubscribed rights issue

THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA OR ANY OTHER JURISDICTION IN WHICH SUCH ACTIONS, WHOLLY OR IN PART, WOULD BE UNLAWFUL OR DEMAND ADDITIONAL REGISTRATION OR OTHER MEASURES BEYOND WHAT IS REQUIRED UNDER SWEDISH LAW. PLEASE REFER TO “IMPORTANT INFORMATION” IN THE END OF THIS PRESS RELEASE.12 August 2022 – The final outcome in Cantargia AB’s (publ) (“Cantargia” or the “Company”

Enhertu approved in US for HER2-mutant NSCLC

12 August 2022 07:00 BST Enhertu approved in the US as the first HER2-directed therapy for patients with previously treated HER2-mutant metastatic non-small cell lung cancer Based on DESTINY-Lung02 results which showed AstraZeneca and Daiichi Sankyo's Enhertu reported a confirmed objective response rate of 57.7% in patients with HER2-mutant disease AstraZeneca and Daiichi Sankyo's Enhertu (trastuzumab deruxtecan) has been approved in the US for the treatment of adult patients with unresectable or metastatic non-small cell lung cancer (NSCLC) whose tumours have activating HER2 (

Oneflow interim report Q2 2022: New all-time-high in sales

Press releaseAugust 12, 2022 Oneflow publishes its interim report for the second quarter of 2022.April - June 2022 (compared to the same period last year) · Net sales increased 59% to MSEK 16.5 (10.3). Share of Net sales outside Sweden increased to 24% (17) with paying users in 27 countries. · EBIT was MSEK -13.4 (-7.1), with an EBIT margin of -81.3% (-69.1). · Basic earnings per share amounted to SEK -0.58 (-0.39) and diluted to SEK -0.58 (-0.39). · Total ARR increased 66% to MSEK 74.7 (45.1). Net New ARR for the second quarter increased 28% to MSEK 9.0 (7.0). ·

Half-Year Report for the First Half of 2022

April – June 2022     · Net sales totaled SEK 21,093 (19,535) thousand, with a growth rate of 8%. Growth is -4%, adjusted for currency effects. · Gross profit rose by 28% to SEK 22,155 (17,365) thousand. · Operating profit before depreciation and amortization (EBITDA) totaled SEK 2,109 (2,793) thousand. · Operating profit declined by SEK 1,129 thousand and totaled SEK 221 (1,350) thousand. · Comprehensive income for the period totaled SEK 811 (1,033) thousand. · Comprehensive income per share totaled SEK 0.01 (0.02). · Cash flow from operating activities was SEK 184 (-1,

CS MEDICA A/S: Publication of interim report Q3

CS MEDICA (”CS MEDICA” or the ”Company”) hereby publishes its interim report for the period October 2021 – June 2022. The report is available as an attached document to this press release and on the Company's website (www.cs-medica.com). Below is a summary of the report.Performance highlights third quarter (April 2022 – June 2022)This year we have invested heavily in preparing our product portfolio for commercial success to reinforce proof-of-content. We were delayed due to COVID-19 with clinical trials, trademarks and our technology platforms CIM/PIM, which are now live. Additionally,

Interim report 1 January – 30 June 2022

Deliveries in Germany under way as per agreement and establishment in the United Kingdom through acquisition in augustSECOND QUARTER 2022 · Net sales increased by 22 percent to MSEK 216 (177). In unchanged currency levels, net sales increased by 19 percent. · Operating profit before amortization of intangible assets (EBITA) decreased by 39 percent to MSEK 11 (18) including negative currency effects of MSEK -3.2 (-0.1). · Cash flow from operating activities amounted to MSEK -13 (15). · Earnings per share amounted to SEK 0.40 (0.70). · During the period, solidity decreased to

Remedy Entertainment's Half-Year Financial Report 2022: Q2 revenue at the previous year's level - increased external development investments burden profitability

Remedy Entertainment Plc | Stock exchange release, August 12, 2022, at 09:00 a.m. (EEST)  Remedy Entertainment Plc | Half-Year Financial Report January–June 2022 Remedy’s Q2 revenue at the previous year’s level – increased external development investments burden profitability Five games in development, including the remake of iconic Max Payne   The Half-Year Financial Report is unaudited. Figures in parenthesis refer to the comparison period in the previous year, unless otherwise stated. HIGHLIGHTS FROM APRIL–JUNE 2022 · Revenue was at the previous year’s level, EUR

Nordic Iron Ore AB prolongs the short-term loan facilities

During 2021 and 2022 Nordic Iron Ore AB has taken up loan facilities of SEK 15.5 million from the Company's three largest owners Bengtssons Tidnings AB, Ludvika Holding AB and Kopparinvest AB as well as the company's board member Timo Lindborg via company. The motivation for the facilities was to provide working capital for evaluating of the Company's financing options. The evaluation on financing options as well as the negotiations with Cargill is progressing and therefore the facilities has now been extended by three months to run through December 2022. Summary of the terms of the

Navamedic ASA: Q2 and first half 2022 financial results

Oslo, 12 August 2022 - Navamedic ASA (OSE: NAVA), a Nordic pharma company and reliable provider of high-quality products to hospitals and pharmacies, grew revenues by 67.2 percent in Q2 2022 compared to the same period in 2021 to NOK 110.4 million, driven by growth in the company’s key business areas. Navamedic reiterates its mid- to long-term ambition of building a NOK 1 billion company.“We are pleased to report record-high revenues and continued strengthening of our profits and cash flow in the second quarter. This was a result of strong growth across several key  products, particularly

Irisity AB (publ) delivers growth with strengthened margins and improved profitability.

The CEO comments on the second quarter: Irisity continues its growth journey with maintained investment pace and cost control. Our net sales increased 60% on an organic basis and by 144% to SEK 31.9 million (13.1) including acquisitions. The gross margin strengthened during the quarter to 83.4 percent (58.2), and the monthly recurring revenue (MRR) was SEK 5.5 million (7.0) Q/Q. We turned to positive EBITDA, which amounted to SEK 1.2 million (-2.6) including extensive pilot installations. The net result was negative because of large amortization of goodwill and intangible assets after

Kamux Corporation’s Half Year Financial Report January 1-June 30, 2022: Kamux increased its revenue by +7.9% in a challenging market environment, but adjusted operating profit decreased significantly

Kamux Corporation Half Year Financial Report 12.8.2022 at 09:00   Kamux Corporation’s Half Year Financial Report for January 1-June 30, 2022: Kamux increased its revenue by +7.9% in a challenging market environment, but adjusted operating profit decreased significantly   This is a summary of Kamux Corporation’s Half Year Financial Report for January 1-June 30, 2022. The complete report is attached to this release and is also available at the company website at www.kamux.com. The figures in parentheses refer to the comparison period, i.e., the same period in the previous year,

Invitation to presentation of Synsam Group’s Q2 report 2022

Presentation in Swedish, with possibility to ask questions · Date and time: 24 August 2022, at 09.00 CEST. · Place: Webcast with teleconference. · Speakers: President and CEO Håkan Lundstedt and CFO Per Hedblom. · Registration for participation in webcast with teleconference:https://financialhearings.com/event/43977  Presentation in English, with possibility to ask questions · Date and time: 24 August 2022, at 10:30 CEST. · Place: Webcast with teleconference. · Registration for participation in webcast with teleconference:https://financialhearings.com/

Archer Limited: Second quarter and first half 2022 results

Hamilton, Bermuda (August 12, 2022) Second Quarter 2022 Highlights · Revenue of $247 million · EBITDA before exceptional items of $20.9 million · Available liquidity of $97 million Subsequent events · Agreed to acquire 50% of Iceland Drilling for $8.25 million · Achieved world record in well intervention at 12.4 kilometers Dag Skindlo, CEO of Archer, comments: “With our investment in Iceland Drilling we anchor our commitment to the ongoing energy transition.  Iceland Drilling is a leading geothermal drilling and well services company, has annual revenue of

SimCorp reports ARR (LTM) growth of 11.9% in H1 2022, as the journey towards being a SaaS provider progresses as planned

Company Announcement no.  36/2022Q2 2022 highlights · Total order intake was EUR 17.0m (EUR 30.2m in Q2 2021). · Strategic agreement signed with Challenger to launch a new stand-alone company to provide investment administration services. · Revenue was EUR 116.0m, a decrease of 2.3% compared with a relatively strong Q2 2021. · EBIT was EUR 6.2m (EUR 30.0m in Q2 2021) and the EBIT margin was 5.4% (25.2% in Q2 2021). · Net profit was EUR 9.3m (EUR 21.3m in Q2 2021). · User conference held in Nice in Q2 2022 with more than 500 clients and partners participating. ·

Biljana Pehrsson appointed new CEO of Nordr Sweden

Biljana Pehrsson has been appointed as new CEO for Nordr Sweden, Scandinavia’s third largest housing developer. She will join the Nordr group management team and will join the company on 15 August.- Biljana is one of the most senior and respected names in real estate. With her on board we have a strong, experienced, and skillful leader with vast knowledge of business, leadership and entrepreneurship. I am both proud and happy that we have achieved to fulfil this recruitment, says Nordr Group CEO Andreas Martinussen. Biljana Pehrsson was appointed CEO at Castellum in November 2021 after

Invitation to telephone conference in connection with Green Landscaping Group quarterly report January-June 2022

Green Landscaping Group publishes its interim report for the second quarter of 2022 on 19 August at 07:00 CEST.CEO Johan Nordström and CFO Carl-Fredrik Meijer will present the report and answer questions during a telephone conference with a web presentation on 19 August at 10:00 CEST. Participants dial in: SE: +46 8 505 163 86UK: +44 20 3198 4884US: +1 412 317 6300 PIN code for all numbers above: 5164427# Webcast: https://tv.streamfabriken.com/green-landscaping-group-q2-2022 The presentation will be held in English.

Techstep ASA: Invitation to presentation of Q2 2022 financial results

Techstep ASA will release its second quarter 2022 financial results on Friday 19 August 2022 at 07:00 CET. The quarterly report and presentation will be made available on the company's website: www.techstep.io/investor, as well as on www.newsweb.no.   The Q2 presentation will be given in English by CEO, Børge Astrup and CFO, Anita Huun.  A Q&A session will take place as a virtual event on 19 August at 08:00 CET. Please join the Teams-session via the following link: https://bit.ly/3QhpDdF    Questions for the Q&A session may be submitted in advance to ir@techstep.io, or live during

Kesko’s sales in July

Kesko Group's sales in July totalled €920.8 million, representing a decrease of 3.6% in comparable terms. In July the number of delivery days was down by one year-on-year.”Kesko’s sales were at a good level in July, but down from the high level seen a year ago. Sales development was impacted by the lower number of delivery days in grocery trade and building and technical trade compared to the year before,” says Mikko Helander, Kesko’s President and CEO. Sales in the grocery trade division totalled €504.7 million in July, down by 2.0%. Sales to K Group grocery stores decreased by 4.0%

Pihlajalinna Half Year Financial Report 1 January–30 June 2022 (6 months)

Pihlajalinna Plc                   Half Year Financial Report                         12 August 2022 at 8:00 a.m. Pihlajalinna Half Year Financial Report 1 January–30 June 2022 (6 months) Revenue increased considerably, Pohjola Hospital’s services have been integrated as a part of the expansion of service network This half year financial report is unaudited. The comparison figures in brackets refer to the corresponding period in the previous year. A brief look at April–June: · Revenue amounted to EUR 173.7 (142.5) million – an increase of EUR 31.2 million, or 21.9 per cent.

There are no items matching the current filter
There are no more items matching the current filter
Back to top